May / June 2020


Clinical trial lessons for managing diabetic retinopathy

Key clinical trials can help us determine how to individualize treatment plans for patients with diabetic retinopathy.

Retina Debate: Is navigated laser the answer for DME?

Its use to treat diabetic macular edema has increased, but not without controversy. These two experts debate its merits.

More frequent dosing for refractory nAMD?

A closer look at biweekly anti-VEGF dosing for chronic disease that doesn’t respond completely to standard monthly dosing.

New revelations for nAMD, CSC treatments and ILM utility

Trial readouts on improving treatment durability, a potential new therapy for central serous chorioretinopathy and adding to the debate of RRD repair.


Clinical Trial Closeup

Targeting a key GA factor at its source

Investigational treatment FB-LRX targets complement factor B further up the complement cascade.

Coding Commentary

Documentation still counts

In the COVID-19 pandemic, one old rule still applies: If you didn’t write it down, you didn’t do it.

Editor's Page

Imaging Forum

Flashing, blind spots and retinal dots

Multimodal imaging helps clinch the diagnosis.


Social Media Specialist

When unhappy patients vent online

How retina specialists can address negative online reviews and unfavorable comments on social media.

Surgical Pearl Video

Fixing a malpositioned infusion cannula

Setting it right during pars plana vitrectomy can avoid serious complications later on.

Uveitis Forum

Managing TRC in posterior uveitis

Guidance for detecting and managing toxoplasmosis retinochoroiditis.